Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient

NCT03153306 is registered in ClinicalTrials.gov with Hainan People's Hospital as lead sponsor.

NCT NCT03153306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03153306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient
Lead sponsor
Hainan People's Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2016
Completion date
March 31, 2018
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis